1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	HIV-1	HIV-1	_	_	_	_	_	_	_
4	replication	replication	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	cysteine	cysteine	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	cysteine	cysteine	_	_	_	_	_	_	_
13	derivatives	derivative	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	HIV-1	HIV-1	_	_	_	_	_	_	_
2	proviral	proviral	_	_	_	_	_	_	_
3	DNA	dna	_	_	_	_	_	_	_
4	contains	contain	_	_	_	_	_	_	_
5	two	two	_	_	_	_	_	_	_
6	binding	bind	_	_	_	_	_	_	_
7	sites	site	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	transcription	transcription	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B.	B.	_	_	_	_	_	_	_
14	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
15	individuals	individual	_	_	_	_	_	_	_
16	have	have	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	on	on	_	_	_	_	_	_	_
19	average	average	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	abnormally	abnormally	_	_	_	_	_	_	_
22	high	high	_	_	_	_	_	_	_
23	levels	level	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	tumour	tumour	_	_	_	_	_	_	_
26	necrosis	necrosis	_	_	_	_	_	_	_
27	factor	factor	_	_	_	_	_	_	_
28	alpha	alpha	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	TNF	TNF	_	_	_	_	_	_	_
31	alpha	alpha	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	abnormally	abnormally	_	_	_	_	_	_	_
35	low	low	_	_	_	_	_	_	_
36	plasma	plasma	_	_	_	_	_	_	_
37	cysteine	cysteine	_	_	_	_	_	_	_
38	levels	level	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	therefore	therefore	_	_	_	_	_	_	_
3	investigated	investigate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	effects	effect	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	cysteine	cysteine	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	related	related	_	_	_	_	_	_	_
10	thiols	thiol	_	_	_	_	_	_	_
11	on	on	_	_	_	_	_	_	_
12	HIV-1	HIV-1	_	_	_	_	_	_	_
13	replication	replication	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	experiments	experiment	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	report	report	_	_	_	_	_	_	_
6	show	show	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	cysteine	cysteine	_	_	_	_	_	_	_
9	or	or	_	_	_	_	_	_	_
10	N-acetylcysteine	N-acetylcysteine	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	NAC	NAC	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	raise	raise	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	intracellular	intracellular	_	_	_	_	_	_	_
17	glutathione	glutathione	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	GSH	GSH	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	level	level	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	inhibit	inhibit	_	_	_	_	_	_	_
24	HIV-1	HIV-1	_	_	_	_	_	_	_
25	replication	replication	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	persistently	persistently	_	_	_	_	_	_	_
28	infected	infected	_	_	_	_	_	_	_
29	Molt-4	molt-4	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	U937	u937	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	inhibition	inhibition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	HIV-1	HIV-1	_	_	_	_	_	_	_
6	replication	replication	_	_	_	_	_	_	_
7	appears	appear	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	be	be	_	_	_	_	_	_	_
11	directly	directly	_	_	_	_	_	_	_
12	correlated	correlate	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	GSH	gsh	_	_	_	_	_	_	_
15	levels	level	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Cysteine	Cysteine	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	NAC	NAC	_	_	_	_	_	_	_
4	also	also	_	_	_	_	_	_	_
5	inhibit	inhibit	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	as	as	_	_	_	_	_	_	_
10	determined	determine	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	electrophoretic	electrophoretic	_	_	_	_	_	_	_
13	mobility	mobility	_	_	_	_	_	_	_
14	shift	shift	_	_	_	_	_	_	_
15	assays	assay	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
18	acetyl-transferase	acetyl-transferase	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	CAT	CAT	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	gene	gene	_	_	_	_	_	_	_
23	expression	expression	_	_	_	_	_	_	_
24	under	under	_	_	_	_	_	_	_
25	control	control	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	NF-kappa	NF-kappa	_	_	_	_	_	_	_
28	B	B	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	sites	site	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	uninfected	uninfected	_	_	_	_	_	_	_
33	cells	cell	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	suggests	suggest	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	cysteine	cysteine	_	_	_	_	_	_	_
6	deficiency	deficiency	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
9	individuals	individual	_	_	_	_	_	_	_
10	may	may	_	_	_	_	_	_	_
11	cause	cause	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	over-expression	over-expression	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B-dependent	b-dependent	_	_	_	_	_	_	_
17	genes	gene	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	enhance	enhance	_	_	_	_	_	_	_
20	HIV-1	HIV-1	_	_	_	_	_	_	_
21	replication	replication	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	NAC	NAC	_	_	_	_	_	_	_
2	may	may	_	_	_	_	_	_	_
3	be	be	_	_	_	_	_	_	_
4	considered	consider	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	treatment	treatment	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
10	individuals	individual	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

